High PFKFB3 mRNA expression correlates with poor survival in renal cancer, progression-free, and distant metastatic-free survival in human epidermal growth factor receptor 2 (HER2) positive breast cancer patients17,18. This evidence concerns the gene ERBB2 and breast cancer.